Variable

No of patients

Univariate P

Multivariate P

HR

95% CI

Age

<70

≥70

n = 37

n = 15

0.04

0.03

3.4

1.2 - 10.2

Gender

M

F

n = 34

n = 18

0.12

WBC (/μl)

<6500

≥6500

n = 33

n = 19

0.12

Neutrophil (/μl)

<5000

≥5000

n = 41

n = 11

0.38

Lymphcyte (/μl)

<1200

≥1200

n = 15

n = 37

0.92

NLR

<5

≥5

n = 48

n = 4

0.63

AST (IU/l)

<20

≥20

n = 30

n = 22

0.7

ALT (IU/l)

<30

≥30

n = 34

n = 18

0.62

T.Bil (mg/dl)

<0.8

≥0.8

n = 43

n = 9

0.38

T.P (g/dl)

<6.0

≥6.0

n = 6

n = 46

0.49

Alb (g/dl)

<3.5

≥3.5

n = 9

n = 43

0.78

CEA (ng/ml)

<5.0

≥5.0

n = 9

n = 43

0.15

CA19-9 (U/ml)

<60

≥60

n = 29

n = 23

0.89

CRP(mg/dl)

<1

≥1

n = 39

n = 13

0.81

GPS

<1

≥1

n = 36

n = 16

0.87

Tumor location

Colon

Rectum

n = 43

n = 9

0.76

Pathology

Diff

Non diff

n = 50

n = 2

0.31

Serosal invasion

Yes

No

n = 17

n = 35

0.41

Vascular invasion

Yes

No

n = 38

n = 14

0.51

Lymphatic invasion

Yes

No

n = 20

n = 32

0.13

Lymph-node metastasis

Yes

No

n = 35

n = 17

0.12

Hepatic metastasis

Yes

No

n = 4

n = 48

<0.01

0.06

2.9

1.0 - 9.1

Lung metastasis

Yes

No

n = 3

n = 49

0.90

Peritoneal metastasis

Yes

No

n = 3

n = 49

0.41

Chemotherapy

Yes

No

n = 43

n = 9

0.01

0.09

3.0

0.1 - 1.1